Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Atai Capital Management Brandon Daniel | “We first wrote about Trifast in our Q4-2025 letter to partners, and it was redacted in the public version of our letters – since our last update, the company has been performing well and to our expectations. After that letter, I posted a more lengthy version of the idea on an investment forum in early June and have shared a slightly updated version here for you all. We believe Trifast offers us the opportunity to buy a decent business at a rock-bottom valuation, with earnings set to inflect significantly. This opportunity comes to us following several temporary headwinds: a difficult, multi-year ERP implementation, a cyclical end-market downturn, and numerous operational inefficiencies caused by a prior management team that eventually led the company to sell certain products at a loss. However, since late 2023, the business has been led by a new management team that has successfully executed on a multi-year turnaround plan. Based on our run-rate earnings estimate, we believe Trifast trades at less than 9.0x UFCF at the time of writing after deducting leases, SBC, and capex. This multiple is far too low for a business that has made several operational improvements over the past several years, has significant operating leverage left to garner, should likely grow the topline at LSD-MSD, and previously traded at a much higher multiple when the business was of lower quality. Trifast is a C-Class component manufacturer and distributor of industrial fastenings (think nuts, bolts, screws, and washers). The primary value-add for their customers isn't the products themselves, which are largely commoditized, but rather the Vendor Managed Inventory (VMI) service that Trifast provides. Under the old management team, Trifast was very focused on top-line growth, with little regard for ROCE, cost controls, customer contract structures, and margins. Since then, Trifast has implemented a three-part plan they call Recover, Rebuild, Resilience. Trifast's Recover, Rebuild, Resilience transformation began shortly after the appointment of current CEO Iain Percival in September of 2023, following the resignation of long-tenured CEO Mark Belton earlier that year, alongside a profit warning. Shortly after Iain's hiring, the board also appointed activist investor Harwood Capital's Nicholas Mills to the board in October of that same year – Harwood is the largest shareholder of Trifast today, owning ~20.5% of the company after purchasing additional shares in March and July of this year as shares traded down. The new management team has exited 1,000+ low-margin or unprofitable customer accounts, implemented new, much stricter pricing and procurement policies, including indexed linked pricing to avoid the impact of raw material costs, with other cost recovery mechanisms implemented where/when needed. These changes have led to value-based pricing across Trifast's existing customer base, which the company did not have previously. In addition to these contract changes, the company has undergone several other typical turnaround procedures, such as several distribution/manufacturing facility rationalizations, headcount reductions, the completion of a companywide ERP system called Project Atlas, and a focus on higher-growth end markets. All of these improvements have led to gross and EBIT margins expanding from 25% and 5%, respectively, in 2023 to ~30% and ~9.5% today, despite significant end-market weakness this year. Based on what we know, it appears that the company continues to execute well on its cost-saving and efficiency initiatives as of the most recent trading update in July. Despite missing on the topline, $207M vs $214M guided, due to factors mostly outside their control, the company still hit their bottom-line guide, which points to further improvements in gross margins and SG&A reductions. They are also already at/very near their medium-term EBIT margin target of 10% (based on their 2nd half of FY26, backing into EBIT margins, they are at ~9.5%) and should still have several opportunities to expand margins further as contracts continue to reprice and operating leverage kicks in. Furthermore, the CEO also purchased ~$100K back in February of this year at $0.80/share, and stated in the July that Our pipeline is the strongest since the strategy was implemented. With increasing exposure to higher-growth areas such as Smart Infrastructure, Medical Equipment and India, and supported by scalable systems and improved commercial execution, we are well positioned to transition from rebuilding margins to rebuilding revenue. As of the time of writing, at $0.86/share, Trifast has a market cap of $117M, ~$16M in net debt, so an EV of ~$133M. While not obvious to the market yet, we believe they are already run-rating at $15M+ in UFCF compared to what was $12M in UFCF for FY26 (ended in March). I'll be honest and say I have no clue what normalized earnings look like for this business, given that a healthy chunk is still coming from UK/EU automotive. The amount of business they've walked away from in the past few years is also somewhat of a question mark. Still, I don't believe it is unreasonable to assume this business can return/get to LSD-MSD revenue growth, given their continued focus on diversifying their end-markets. However, let's just assume that they can hit $220M in revenue at 12% EBIT margins by the end of 2028, that'd imply $20M in UFCF and the stock would be trading at ~6.5x today, presumably by then their end market mix would be more attractive and they'd be growing at a more sustainable LSD-MSD clip. Their publicly listed peers Bufab and Bossard trade at 15x-25x earnings, have EBIT margins in the 10-15% range, and gross margins in the low thirties. Trifast pre-COVID traded at 15x-20x with ~11% EBIT margins, when it was perceived as a better business than it actually was once you looked under the hood. We obviously believe the company is in a much better place now than it was back then, despite the lack of topline growth in recent years, which we believe is mostly due to the company purposefully choosing to prune bad business and the cyclical downturn in some of their end markets. Anyways, running with $20M in UFCF at a 12.5x multiple before cash generation gets me to $1.70 a share or ~100% upside. This scenario does not seem unrealistic to us, and even if it doesn't play out as expected, we don't believe today's earnings are likely to go anywhere, nor do we believe 9.0x run-rate UFCF is remotely the correct multiple for this business. Once you start modeling out peer-level margins and multiples, plus give them some credit for cash generation over the next few years, the upside starts to get a bit absurd on this one, with significant downside protection today.” | NEUTRAL | Q2 2026 Aug 26, 2026 | View Pitch |
Rockwood Strategic Richard Staveley | “Trifast is an international fastener distributor and manufacturer undergoing an early-stage turnaround under a refreshed executive team. Completion of an ERP rollout and inventory reductions are expected to lower debt and boost cash flow. With operating margins depressed relative to historical levels, restoring margins to target levels offers over 100% upside.” | BULL | Q2 2024 Jun 30, 2024 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
